Dorsey & Whitney Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,017
Closed -$283K 705
2025
Q1
$283K Buy
19,017
+3,221
+20% +$49.5K 0.02% 532
2024
Q4
$236K Buy
+15,796
New +$257K 0.01% 596

Other funds holding OGN

Dorsey & Whitney Trust's OGN Position: Q2 2025 in Review

Dorsey & Whitney Trust sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 19,017 shares — an estimated $283K sold.

Dorsey & Whitney Trust first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $283K in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Dorsey & Whitney Trust reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 19,017 Organon & Co shares in Q2 2025, an estimated $283K.
  • Dorsey & Whitney Trust first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
  • Dorsey & Whitney Trust's Organon & Co position peaked at $283K in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2025, filed 11 Aug 2025.